Pepdox
Studies
Peptides
Calculator
Home
/
Search
/
PMID 37385274
SURMOUNT-2: new advances for treating obese type 2 diabetes with tirzepatide.
Lancet (London, England)
2023
PMID: 37385274
View on PubMed
DOI: 10.1016/S0140-6736(23)01292-8
Tirzepatide
Authors
Frandsen, Christian Seerup; Madsbad, Sten
SURMOUNT-2: new advances for treating obese type 2 diabetes with tirzepatide. | Pepdox